TipRanks
HLB Life Science Co.,Ltd. (KR:067630)
:067630
South Korea Market
067630
HLB Life Science Co.,Ltd.
RESEARCH TOOLSreports

HLB Life Science Co.,Ltd. (067630) Ratios

― Followers

HLB Life Science Co.,Ltd. Ratios

KR:067630's free cash flow for Q4 2025 was ₩-0.21. For the 2025 fiscal year, KR:067630's free cash flow was decreased by ₩ and operating cash flow was ₩-2.87. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.58 0.58 2.90 1.09 6.00
Quick Ratio
 0.51 0.52 2.79 1.05 5.60
Cash Ratio
 0.08 0.11 0.98 0.12 1.16
Solvency Ratio
 -0.14 -0.52 0.09 <0.01 -0.28
Operating Cash Flow Ratio
 -0.22 -0.19 -0.60 -0.07 -1.11
Short-Term Operating Cash Flow Coverage
 -0.27 -0.22 -0.79 -0.09 -3.58
Net Current Asset Value
₩ -117.38B₩ -111.42B₩ 15.10B₩ -45.24B₩ -14.95B
Leverage Ratios
Debt-to-Assets Ratio
 0.34 0.34 0.23 0.39 0.36
Debt-to-Equity Ratio
 0.56 0.54 0.31 0.72 0.63
Debt-to-Capital Ratio
 0.36 0.35 0.24 0.42 0.39
Long-Term Debt-to-Capital Ratio
 0.18 0.15 0.17 0.18 0.37
Financial Leverage Ratio
 1.66 1.61 1.35 1.83 1.75
Debt Service Coverage Ratio
 -0.41 -0.72 0.51 0.17 -2.16
Interest Coverage Ratio
 -1.88 -1.79 -1.48 -1.13 -2.04
Debt to Market Cap
 0.36 0.11 0.10 0.12 0.13
Interest Debt Per Share
 1.41K 1.41K 1.30K 1.76K 1.47K
Net Debt to EBITDA
 -3.27 -1.76 2.75 6.56 -2.55
Profitability Margins
Gross Profit Margin
-7.56%-1.08%-2.14%-0.76%-3.06%
EBIT Margin
-97.81%-194.14%19.53%15.46%-51.18%
EBITDA Margin
-83.88%-182.67%25.30%23.31%-45.93%
Operating Profit Margin
-42.33%-45.95%-24.27%-25.04%-20.24%
Pretax Profit Margin
-61.84%-219.81%3.08%-6.64%-61.09%
Net Profit Margin
-60.65%-218.12%6.00%-6.11%-54.58%
Continuous Operations Profit Margin
-60.82%-218.35%6.07%-6.03%-54.58%
Net Income Per EBT
98.07%99.23%194.90%92.01%89.35%
EBT Per EBIT
146.09%478.39%-12.69%26.51%301.76%
Return on Assets (ROA)
-7.04%-20.87%1.14%-1.41%-13.20%
Return on Equity (ROE)
-11.48%-33.56%1.54%-2.59%-23.16%
Return on Capital Employed (ROCE)
-6.59%-5.85%-5.11%-8.52%-5.24%
Return on Invested Capital (ROIC)
-5.08%-4.51%-4.71%-5.54%-4.56%
Return on Tangible Assets
-7.91%-23.41%1.24%-1.63%-16.97%
Earnings Yield
-7.57%-7.23%0.50%-0.44%-4.80%
Efficiency Ratios
Receivables Turnover
 2.64 2.00 5.06 6.69 6.40
Payables Turnover
 13.70 17.24 14.95 19.13 10.94
Inventory Turnover
 7.48 6.81 17.11 18.75 9.44
Fixed Asset Turnover
 0.42 0.35 1.26 1.34 1.08
Asset Turnover
 0.12 0.10 0.19 0.23 0.24
Working Capital Turnover Ratio
 -1.00 1.76 1.80 1.35 0.72
Cash Conversion Cycle
 160.57 214.99 68.99 54.95 62.30
Days of Sales Outstanding
 138.42 182.56 72.07 54.56 57.03
Days of Inventory Outstanding
 48.80 53.60 21.33 19.47 38.65
Days of Payables Outstanding
 26.64 21.17 24.41 19.08 33.37
Operating Cycle
 187.21 236.16 93.41 74.02 95.68
Cash Flow Ratios
Operating Cash Flow Per Share
 -218.38 -188.11 -295.35 -93.75 -278.41
Free Cash Flow Per Share
 -340.04 -400.90 -548.80 -295.20 -387.49
CapEx Per Share
 121.66 212.79 253.46 201.45 109.08
Free Cash Flow to Operating Cash Flow
 1.56 2.13 1.86 3.15 1.39
Dividend Paid and CapEx Coverage Ratio
 -1.79 -0.88 -1.17 -0.47 -2.55
Capital Expenditure Coverage Ratio
 -1.79 -0.88 -1.17 -0.47 -2.55
Operating Cash Flow Coverage Ratio
 -0.17 -0.14 -0.26 -0.06 -0.20
Operating Cash Flow to Sales Ratio
 -0.49 -0.50 -0.31 -0.10 -0.30
Free Cash Flow Yield
-9.51%-3.54%-4.85%-2.30%-3.66%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -13.14 -13.83 199.86 -229.44 -20.83
Price-to-Sales (P/S) Ratio
 8.01 30.16 12.00 14.01 11.37
Price-to-Book (P/B) Ratio
 1.54 4.64 3.08 5.95 4.82
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.51 -28.24 -20.63 -43.53 -27.36
Price-to-Operating Cash Flow Ratio
 -16.37 -60.18 -38.33 -137.07 -38.07
Price-to-Earnings Growth (PEG) Ratio
 0.05 <0.01 -0.98 2.56 -1.46
Price-to-Fair Value
 1.54 4.64 3.08 5.95 4.82
Enterprise Value Multiple
 -12.82 -18.27 50.17 66.66 -27.30
Enterprise Value
 584.74B 1.53T 1.30T 1.52T 1.25T
EV to EBITDA
 -12.82 -18.27 50.17 66.66 -27.30
EV to Sales
 10.75 33.38 12.69 15.54 12.54
EV to Free Cash Flow
 -14.11 -31.25 -21.82 -48.28 -30.17
EV to Operating Cash Flow
 -21.98 -66.59 -40.55 -152.02 -41.99
Tangible Book Value Per Share
 1.90K 2.02K 3.27K 1.64K 1.35K
Shareholders’ Equity Per Share
 2.31K 2.44K 3.68K 2.16K 2.20K
Tax and Other Ratios
Effective Tax Rate
 0.01 <0.01 -0.97 0.09 0.11
Revenue Per Share
 446.46 375.28 943.47 917.20 932.19
Net Income Per Share
 -270.77 -818.56 56.64 -56.01 -508.81
Tax Burden
 0.98 0.99 1.95 0.92 0.89
Interest Burden
 0.63 1.13 0.16 -0.43 1.19
Research & Development to Revenue
 0.08 0.10 0.05 0.06 0.04
SG&A to Revenue
 0.08 0.10 0.05 0.06 0.04
Stock-Based Compensation to Revenue
 <0.01 <0.01 0.00 0.00 0.00
Income Quality
 0.80 0.23 -5.16 1.69 0.55
Currency in KRW